AI assistant
Plus500 Ltd. — Director's Dealing 2020
Apr 14, 2020
6292_dirs_2020-04-14_119eb578-f7ad-40bf-a1af-83415e8f233e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 4675J
Plus500 Limited
14 April 2020
14 April 2020
Plus500 Ltd.
("Plus500" or "the Company")
Director/ PDMR Dealing
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The following notification is made under article 19 of the Market Abuse Regulation.
1
Details of PDMR / person closely associated with them ("PCA")
(a)
Name
Julie Winton
2
Reason for the notification
(a)
Position/status
PCA - Spouse of Mark Winton - PDMR
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Plus500 Ltd.
(b)
LEI
549300X8NGW9C5OJZU13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Identification code
Ordinary shares of NIS 0.01 par value ("Shares")
IL0011284465
(b)
Nature of the transaction
Purchase of Shares
(c)
Price(s) and volume(s)
Price: £10.809
Volume: 3,699
(d)
Aggregated information
N/A (a single transaction)
(e)
Date of the transaction
8 April 2020
(f)
Place of the transaction
London Stock Exchange
1
Details of PDMR / person closely associated with them ("PCA")
(a)
Name
Michael Charles Fairbairn
2
Reason for the notification
(a)
Position/status
Director
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Plus500 Ltd.
(b)
LEI
549300X8NGW9C5OJZU13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Identification code
Ordinary shares of NIS 0.01 par value ("Shares")
IL0011284465
(b)
Nature of the transaction
Sale of Shares
(c)
Price(s) and volume(s)
| Prices (£) (rounded to the nearest penny) | Volumes |
| 11.12 | 3,000 |
| 11.03 | 500 |
| 10.99 | 500 |
| 11.02 | 500 |
| 11.09 | 2,500 |
| 11.10 | 2,000 |
| 11.06 | 2,000 |
| 11.08 | 2,000 |
| 11.31 | 2,500 |
| 11.32 | 4,500 |
| 11.16 | 2,000 |
| 11.11 | 737 |
(d)
Aggregated information
Price: £11.163
Volume: 22,737
(e)
Date of the transaction
9 April 2020
(f)
Place of the transaction
London Stock Exchange
1
Details of PDMR / person closely associated with them ("PCA")
(a)
Name
Michael Charles Fairbairn
2
Reason for the notification
(a)
Position/status
Director
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Plus500 Ltd.
(b)
LEI
549300X8NGW9C5OJZU13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Identification code
Ordinary shares of NIS 0.01 par value ("Shares")
IL0011284465
(b)
Nature of the transaction
Purchase of Shares
(c)
Price(s) and volume(s)
| Prices (pence) | Volumes |
| 11.10 | 2,500 |
| 11.09 | 2,500 |
| 11.09 | 2,500 |
| 11.08 | 2,500 |
| 11.12 | 2,500 |
| 11.21 | 2,500 |
| 11.34 | 2,500 |
| 11.36 | 2,500 |
| 11.16 | 2,737 |
(d)
Aggregated information
Price: £11.172
Volume: 22,737
(e)
Date of the transaction
9 April 2020
(f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHDZGMDRFVGGZM